The United Laboratories International Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG8813K1085
  • HKG: 3933
HKD
7.93
-0.07 (-0.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

With ROE of 11.10%, it has a Very Attractive valuation with a 0.86 Price to Book Value

  • Over the past year, while the stock has generated a return of -48.32%, its profits have fallen by -23.7%
  • At the current price, the company has a high dividend yield of 0
2

Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks

 
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 16,107 Million ()

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.36

stock-summary
Return on Equity

11.10%

stock-summary
Price to Book

0.83

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.88%
0%
-3.88%
6 Months
-21.49%
0%
-21.49%
1 Year
-48.51%
0%
-48.51%
2 Years
-7.36%
0%
-7.36%
3 Years
17.48%
0%
17.48%
4 Years
131.2%
0%
131.2%
5 Years
51.05%
0%
51.05%

The United Laboratories International Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.73%
EBIT Growth (5y)
13.11%
EBIT to Interest (avg)
40.96
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.84
Tax Ratio
17.60%
Dividend Payout Ratio
39.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.37%
ROE (avg)
15.26%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.86
EV to EBIT
3.97
EV to EBITDA
3.08
EV to Capital Employed
0.78
EV to Sales
0.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.65%
ROE (Latest)
11.10%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by The United Laboratories International Holdings Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.96% vs -1.74% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -21.68% vs -3.44% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,327.20",
          "val2": "14,917.80",
          "chgp": "-3.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,166.50",
          "val2": "3,757.60",
          "chgp": "-15.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.60",
          "val2": "37.90",
          "chgp": "99.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "92.30",
          "val2": "74.50",
          "chgp": "23.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,257.00",
          "val2": "2,881.70",
          "chgp": "-21.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "171.80%",
          "val2": "207.10%",
          "chgp": "-3.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
14,327.20
14,917.80
-3.96%
Operating Profit (PBDIT) excl Other Income
3,166.50
3,757.60
-15.73%
Interest
75.60
37.90
99.47%
Exceptional Items
92.30
74.50
23.89%
Consolidate Net Profit
2,257.00
2,881.70
-21.68%
Operating Profit Margin (Excl OI)
171.80%
207.10%
-3.53%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -3.96% vs -1.74% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -21.68% vs -3.44% in Dec 2024

stock-summaryCompany CV
About The United Laboratories International Holdings Ltd. stock-summary
stock-summary
The United Laboratories International Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading